Public research preview
David J. Taylor, Representative disclosure: Vertex Pharmaceuticals Incorporated - Common Stock (VRTX)
Disclosed a sell transaction in Vertex Pharmaceuticals Incorporated - Common Stock (VRTX). Use this page to inspect source evidence, confidence scores, filing delay, and post-disclosure price movement before deciding whether to research the signal further.
This public page is for public-disclosure research only. It is not investment advice and does not place orders. Verify the official source before relying on any signal.
Evidence passport
Official-source context and parser confidence before any simulation or alert decision.
- Source
- House STOCK Act disclosures
- Published
- 2 Feb 2026, 00:00
- Parser confidence
- 94%
- Instrument mapping
- 95%
- Filing delay
- 4 days
Timeline
Transaction date
29 Jan 2026
Public disclosure
2 Feb 2026
Now
Tracked today
Filing delay: 4 days
Price movement
Complete coverage
- Provider
- Yahoo Finance daily close
- Fetched
- 7 Aug 2026
Stock path
VRTX from pre-transaction context through latest close.
Transaction
29 Jan 2026 · 475.68 USD · Not public yet
System decision
Would not buy — The strategy's filters reject this signal. Failed filters: Buy disclosure.
- Not public yet
- Would not buy
- Observed transaction close
- 475.68
- Observed disclosure close
- 472.01
- Observed latest close
- 493.18
- Pre-disclosure move
- -0.8%
- Post-disclosure move
- +4.5%
- Market-adjusted move
- -7.1%
- 1w since disclosure
- -0.2%
- 1m since disclosure
- +1.2%
- 3m since disclosure
- -8.9%
- Pre-disclosure peak run-up
- 0.0%
- Retrace from peak
- -0.8%
Why Copy Window is Probably too late
Supporting factors
- Parsed sell disclosure for ordinary shares from House STOCK Act disclosures.
- Reported amount is $1,001 - $15,000.
- Post-disclosure move is calculated from Yahoo Finance daily close daily closes.
Cautions
- Yahoo Finance daily close coverage is end-of-day and should be verified against the official price source.
- Review the original source document before making any investment decision.
Source document
House STOCK Act disclosures, published 2 Feb 2026, 00:00
- Parser confidence
- 94%
- Instrument mapping
- 95%